About NanGenex Inc.
NanGenex is member of the DRGT Group. Headquartered in Dublin, Ireland, Druggability Technologies is dedicated to the development and commercialization of high-value pharmaceutical products that deliver measurable and meaningful improvement in clinical efficacy. This mission is enabled through the deployment of the Group's NanoActive Super-API Technology that delivers substantial improvement in pharmacokinetics / pharmacodynamics / bioavailability resulting in high-value, proprietary products.
One of its subsidiaries, NanGenex Inc, is the technology company that develops and advances to the clinic specific high value compounds (or libraries) from Bio-Pharma partners. The company is based in Budapest and was established in 2006 to develop the continuous flow based NanoActive Technology and the related full scale (scale-down and scale-up), intelligent and integrated, GMP compliant instrument line.